What Is an Investigational New Animal Drug (INAD)

What Is an Investigational New Animal Drug (INAD)? A Regulatory Pathway for Veterinary Drug Development Veterinary medicinal products require rigorous testing to ensure that they are safe and effective for use in animals. In the United States, the development of new animal drugs is governed by the U.S. Food and Drug Administration (FDA) under the… Continue reading What Is an Investigational New Animal Drug (INAD)

Published
Categorized as Regulatory

What Is Corrective Action and Preventive Action (CAPA)?

What Is Corrective Action and Preventive Action (CAPA)? A Critical Quality Management Process in Life Sciences Staying on top of regulatory standards is a must in pharmaceuticals, biotech, and medical devices. When quality issues pop up, companies turn to Corrective Action and Preventive Action better known as CAPA. It’s not just a checkbox, either. CAPA… Continue reading What Is Corrective Action and Preventive Action (CAPA)?

Published
Categorized as Regulatory

Clarification on the Use of the Sister File Procedure-EDQM

Clarification on the Use of the Sister File Procedure-EDQM The current EDQM policy PA/PH/CEP (09) 141, 2R, “Guidance on applications for “sister files”, has guided the sister file procedure for CEPs for many years. Experience gathered over time indicates that there may be discrepancies in the understanding of the procedure and the EDQM has noted… Continue reading Clarification on the Use of the Sister File Procedure-EDQM

Published
Categorized as Regulatory

IMPLEMENTATION OF THE EUROPEAN PHARMACOPOEIA SUPPLEMENT 12.3

IMPLEMENTATION OF THE EUROPEAN PHARMACOPOEIA SUPPLEMENT 12.3 Publication schedule:  Issue Publication date Correction date Implementation date 12.1 07/2025 31/08/2025 01/01/2026 12.2 10/2025 30/11/2025 01/04/2026 12.3 01/2026 28/02/2026 01/07/2026 13.1 04/2026 31/05/2026 01/01/2027 13.2 07/2026 31/08/2026 01/04/2027  

Published
Categorized as Regulatory

What Is an ICSR

What Is an Individual Case Safety Report (ICSR)? A Key Component of Pharmacovigilance Pharmacovigilance plays a vital role in overseeing the safety of medicinal products during the lifecycle of the products. The Individual Case Safety Report (ICSR) is considered to be one of the most significant tools that are employed to monitor and analyze adverse… Continue reading What Is an ICSR

Published
Categorized as Regulatory

What Is an IMPD?

What Is an IMPD? Understanding the Investigational Medicinal Product Dossier Regulatory approval is a pre-requisite prior to initiating any clinical trial that involves any medicinal products in the European Union. Among the most significant papers needed in this procedure is Investigational Medicinal Product Dossier (IMPD).

Published
Categorized as Regulatory

What Is a PADER?

What Is a PADER? Understanding the Periodic Adverse Drug Experience Report Pharmacovigilance plays a critical role in ensuring patient safety throughout a product’s lifecycle. One of the key regulatory requirements in the United States is the Periodic Adverse Drug Experience Report (PADER). This report allows regulatory authorities to continuously evaluate the safety profile of approved… Continue reading What Is a PADER?

What is GMP Inspection?

What is GMP Inspection? In the healthcare and pharmaceutical sectors, Good Manufacturing Practices (GMP) are the foundation of quality and safety of their products. A GMP inspection is a systematic exercise which is conducted by regulatory authorities like FDA ( United States Food and Drug Administration), EMA (European Medicines Agency) or WHO (World Health Organization).

Published
Categorized as Quality

Global GMP & Regulatory Intelligence 2025–2026

Continent-Specific Global GMP and regulatory compliance Updates for API & Pharmaceutical Manufacturers Introduction Regulatory authorities worldwide are strengthening expectations around GMP robustness, quality maturity, contamination control, data integrity, and AI governance in pharmaceutical manufacturing. Global GMP and regulatory compliance updates across Africa, North America, Europe, Asia, and Oceania are increasingly aligned with ICH, PIC/S, WHO,… Continue reading Global GMP & Regulatory Intelligence 2025–2026

Book a Demo